Healthcare -
Biotechnology - NASDAQ - US
$ 9.235
-2.69 %
$ 2.84 B
Market Cap
-51.31
P/E
FOLD - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities FOLD - Amicus Therapeutics, Inc.
5.12 M
LAST VALUE
63.90%
2 YEAR CAGR
-52.75%
5 YEAR CAGR
-28.12%
10 YEAR CAGR